Home Analyst Ratings NeoGenomics Unchanged to Outperform at SVB Leerink

NeoGenomics [NEO] Unchanged to Outperform at SVB Leerink

SVB Leerink maintained its NeoGenomics [NEO] rating to the equivalent of Outperform but changed the price target to $60.0 from $50, in a research note dated 2021-01-08. That figure represents around a 12.11% premium from where the company’s shares closed on Thursday. Other analysts also revised their coverage, with Needham’s analysts reiterating the shares to “a Buy” rating in a research note to investors issued in late October. Meanwhile, Morgan Stanley had launched its coverage on NEO with “an Overweight”, in a research note produced for clients September 09, 2020. In addition, Guggenheim launched coverage on August 28, 2020. The research firm rated NEO “a Buy”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is NeoGenomics Inc. [NASDAQ:NEO] a Good Buy Right Now?

It should be noted that NEO technical indicators for short, intermediate as well as long term progress have placed an overall average of 96% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from NeoGenomics Inc.’s Trend Spotter indicated that the signals were Bullish. The stock current average is 0.98 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.77 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.71 million shares.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

NEO Price Performance

On Wall Street, NeoGenomics Inc. [NASDAQ:NEO] finished Thursday’s session up 4.23% at $53.52. The stock went up to $54.42 at the same session while its lowest single day price was $52.01. In the last five days, it saw a fall of about -1.20%, NeoGenomics Inc. shares dropped by almost -0.59% since the beginning of the year. However, the share price has dropped to as low as -6.22% below its one year high. On 01/05/21, the company shares recorded $55.83, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/06/21, the same year at $48.88. The company’s shares have inclined by 83.10% in the past year. The 50-day SMA achieved is $47.48 while the 200-day SMA is $36.83. Volume gained to 3.89 million from 3.58 million in the previous session.

NEO Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 52.21 level, and in case of violation of this particular level, it will cause more drop to 50.91 level. On the upper level, 55.73 is still the key resistance. The stock may increase to the subsequent resistance at 54.62. The Relative Strength Index (RSI) pinned on the 14-day chart is 56.53, implying a neutral technical stance while the MACD stands at -0.96, meaning price will decrease in the next trading period. Percent R indicator moved to 43.35%, implying low price movement. Stochastic %K at 49.28% suggest selling the stock.

What is the short interest in NeoGenomics Inc.?

Short interest in the NeoGenomics Inc. stock has plunged, decreasing by -0.27 million shares to total 4.71 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 4.44 million, data from Yahoo Finance shows. The increase of 5.73% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 5.90% of the overall float for the stock.

NeoGenomics Inc.’s Biggest Shareholders: Who Owns NeoGenomics Inc. [NEO]?

Filings by BlackRock Fund Advisors showed that the firm now holds a total of 14,935,465 shares or roughly 13.45% of the outstanding NEO shares. This means their shares have reduced by -353,027 from the 14,935,465 the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, The Vanguard Group, Inc. updated stake is worth $502,595,200. Details in the latest 13F filings reveal that Artisan Partners LP disposed off their -4.35% stake valued at $219,370,588 while Brown Advisory LLC added theirs at $179,497,834. During the last quarter, Artisan Partners LP liquidated -209,735 of its shares in NeoGenomics Inc. while Brown Advisory LLC bought 64,095 shares. The Invesco Advisers, Inc.’s holdings currently number 3,726,639 shares at $199449719.28. According to the firm’s last 13F report, Kopp Family Office LLC shares in the company at filing stood at 3,233,015 shares, roughly $153,826,854.

NEO Earnings Forecast For The Current Quarter

NeoGenomics Inc. [NEO] is expected to report weak earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $124.24M and an earnings per share of $0.06 for Dec 2020. Looking further ahead, the company is expected to report revenue of $123.06M at an EPS of $0.06 for Mar 2021. The estimates represent upside of 18.60% and 325.35% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

NEO Earnings Estimates For The Current Year

For the financial year, NeoGenomics Inc. [NASDAQ:NEO] is expected to bring in revenue of $442.53M. The returns are nearly $33.7 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 0.07, lower than that of FY19 by -$0.24. Estimates put this year’s earnings growth at -77.40%, 328.60% for the next, and at an annual 20.00% over the next 5-year period. As for sales, forecasts are for an increase of 8.20% in the current fiscal year and a further 18.60% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

ISun Inc. (ISUN) stock surged during current market trading. Here’s the update

ISun Inc. (NASDAQ: ISUN) stock gained by 19.51% in the current market trading. iSun, based in Burlington, Vermont, is a company built on ideals...

The Trade Desk Inc. (TTD) stock plunged during pre-market. Here’s to know why?

The Trade Desk Inc. (NASDAQ: TTD) stock gained by 0.76% at last close whereas the TTD stock price declines by 90.03% in the pre-market...

Synaptogenix Inc. (SNPX) stock soars during after-hour trading. Why so?

Synaptogenix Inc. (NASDAQ: SNPX) stock gained by 6.33% at last close while the SNPX stock price rises further by 13.48% in the after-hours trading...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

VivoPower International Inc. (VVPR) stock soars during pre-market trading. What’s driving it high?

VivoPower International Inc. (NASDAQ: VVPR) stock gained by 1.13% at last close while the VVPR stock price surged during pre-market trading by 1.54%. VivoPower...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam